Julia Elisabeth Simensen

  • Special Engineer; MSc

Bio:

Julia Simensen studied Molecular Biosciences at the University of Oslo, Norway, from 2014-2020. She performed her Master’s thesis under the supervision of Dr. Viola Lobert (Rusten’s group), where she became interested in colorectal cancer research with focus on studying the disease in 3D cultures (i.e. organoids and spheroids). After MSc graduation in June 2020, she worked as a summer internship student supervised by Dr. Marie Rogne (Eskeland’s group) through the University of Oslo: Life Science program. Here she gained experience in liposarcoma research and molecular techniques used to study cytogenetics, such as fluorescence in situ hybridization (FISH). In September 2020, she was hired by Hovig’s group to participate as an engineer in projects related to Covid-19 and prostate cancer (see listing below). Since April 2021, Simensen is employed as a Special Engineer in the “Autophagy in cancer” project group led by Dr. Nikolai Engedal.

Covid-19 project (September 2020-December 2020)

Lead by Dr. Per O. Ekstrøm

Radiosensitizers in prostate cancer project (September 2020-ongoing)

Urbanucci Lab, led by Dr. Alfonso Urbanucci

Autophagy in prostate cancer project (April 2021-ongoing)

Engedal Lab, led by Dr. Nikolai Engedal

 

 

Publications 2022

Engedal N, Sønstevold T, Beese CJ, Selladurai S, Melcher T, Simensen JE, Frankel LB, Urbanucci A, Torgersen ML (2022)
Measuring Autophagic Cargo Flux with Keima-Based Probes
Methods Mol Biol, 2445, 99-115
DOI 10.1007/978-1-0716-2071-7_7, PubMed 34972988

Lobert VH, Skardal ML, Malerød L, Simensen JE, Algra HA, Andersen AN, Fleischer T, Enserink HA, Liestøl K, Heath JK, Rusten TE, Stenmark HA (2022)
PHLPP1 regulates CFTR activity and lumen expansion through AMPK
Development, 149 (20)
DOI 10.1242/dev.200955, PubMed 35997536

Page visits: 1190